IteraMed
  • Home
  • Services
  • About IteraMed
  • References
  • Useful Links
  • IteraMed News
  • Contact
Select Page

Novel PI3K p110 inhibitors and methods of use thereof

Patents

Novel PI3K p110 inhibitors and methods of use thereof; Katsikis, Peter D.; Kinney, William A.; Almond, Harold R.; Khan, Noshena; PCT Int. Appl. (2013), WO 2013090725 A1 20130620.

Skills

Posted on

November 9, 2015

← Quinoline- ​derived peri-​carbinols useful for treating, reducing a symptom of or reducing the risk of macular degeneration, and preparation thereof

Recent Posts

  • Sports Illustrated Runs Article on “Super-CBD” with Potentional in Traumatic Head Injury
  • Publication at ACS Medicinal Chemistry Letters entitled, “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability”
  • Presentation at Drug Discovery Re-Invented Conference entitled: THE ARCHITECTURE AND SCIENCE OF VIRTUAL DRUG DISCOVERY IN THE CANNABINOID SPACE
  • Home
  • Services
  • About IteraMed
  • References
  • Useful Links
  • IteraMed News
  • Contact

© Copyright 2025 by IteraMed. Website by Grandstaff